Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 369 results:
Συντάκτης [ Τίτλος(Asc)] Τύπος Έτος
Φίλτρα: Συντάκτης is Polyzos, Stergios A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Polyzos, S. A., & Mantzoros C. S. (2023).  Sarcopenia: still in relative definition-penia and severe treatment-penia.. Metabolism. 155717.
Polyzos, S. A., Vachliotis I. D., & Mantzoros C. S. (2023).  Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease.. Metabolism. 147, 155676.
R
Anastasilakis, A. D., Polyzos S. A., & Toulis K. A. (2011).  Role of wingless tail signaling pathway in osteoporosis: an update of current knowledge.. Curr Opin Endocrinol Diabetes Obes. 18(6), 383-8.
Vachliotis, I. D., & Polyzos S. A. (2023).  The Role of Tumor Necrosis Factor-Alpha in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease.. Curr Obes Rep.
Polyzos, S. A., & Targher G. (2024).  Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease.. Curr Obes Rep.
Tsiampali, C., Papaioannidou P., Goulas A., & Polyzos S. A. (2023).  The role of glucagon-like peptide-1 receptor agonists in nonalcoholic fatty liver disease.. Expert Rev Clin Pharmacol. 1-10.
Anastasilakis, A. D., Polyzos S. A., Delaroudis S., Bisbinas I., Sakellariou G. T., Gkiomisi A., et al. (2012).  The role of cytokines and adipocytokines in zoledronate-induced acute phase reaction in postmenopausal women with low bone mass.. Clin Endocrinol (Oxf). 77(6), 816-22.
Papaefthymiou, A., Christodoulidis G., Koffas A., Doulberis M., Polyzos S. A., Manolakis A., et al. (2021).  Role of autophagy in gastric carcinogenesis.. World J Gastrointest Oncol. 13(10), 1244-1262.
Polyzos, S. A., Kountouras J., Zavos C., & Tsiaousi E. (2010).  The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease.. Diabetes Obes Metab. 12(5), 365-83.
Doulberis, M., Papaefthymiou A., Polyzos S. A., Katsinelos P., Grigoriadis N., Srivastava D. S., et al. (2020).  Rodent models of obesity.. Minerva Endocrinol. 45(3), 243-263.
Doulberis, M., Kotronis G., Thomann R., Polyzos S. A., Boziki M., Gialamprinou D., et al. (2018).  Review: Impact of Helicobacter pylori on Alzheimer's disease: What do we know so far?. Helicobacter. 23(1), 
Polyzos, S. A., Kechagias S., & Tsochatzis E. A. (2021).  Review article: non-alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations.. Aliment Pharmacol Ther.
Orfanidou, M., Ntenti C., Evripidou K., Mataftsi A., Goulas A., & Polyzos S. A. (2023).  Retinal Vascular Lesions in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.. J Pers Med. 13(7), 
Kountouras, J., Papaefthymiou A., Polyzos S. A., Zavos C., & Doulberis M. (2020).  Response to letter to the editor of Carcinogenesis by Li et al., 2020.. Carcinogenesis. 41(4), 539-540.
Kountouras, J., Doulberis M., Papaefthymiou A., Polyzos S. A., Touloumtzi M., Vardaka E., et al. (2019).  The relationship between -related microbiota dysbiosis and gastrointestinal tract pathologies.. Scand J Gastroenterol. 1-2.
Makras, P., Yavropoulou M. P., Polyzos S. A., Papapoulos S. E., Georgakopoulou D., Papatheodorou A., et al. (2023).  The relationship between length of denosumab treatment for postmenopausal osteoporosis and serum TRAcP5b measured six months after the last injection.. Osteoporos Int.
Gavalas, E., Kountouras J., Boziki M., Zavos C., Polyzos S. A., Vlachaki E., et al. (2015).  Relationship between Helicobacter pylori infection and multiple sclerosis.. Ann Gastroenterol. 28(3), 353-356.
Kountouras, J., Zavos C., Polyzos S. A., Michael S., Tsiaousi E., Vardaka E., et al. (2013).  Relationship between Helicobacter pylori infection and autoimmune disorders.. Clin Chem Lab Med. 51(5), e73-4.
Kountouras, J., Zavos C., Gavalas E., Deretzi G., Tsona A., Katsinelos P., et al. (2012).  A rebuttal to the potential anti-tumour benefit of Helicobacter pylori-induced neutrophil-activating protein.. Cancer Immunol Immunother. 61(3), 445-6; discussion 447-51.
Anastasilakis, A. D., Toulis K. A., Polyzos S. A., & Terpos E. (2009).  RANKL inhibition for the management of patients with benign metabolic bone disorders.. Expert Opin Investig Drugs. 18(8), 1085-102.
P
Kountouras, J., Deretzi G., Gavalas E., Zavos C., Polyzos S. A., Kazakos E., et al. (2014).  A proposed role of human defensins in Helicobacter pylori-related neurodegenerative disorders.. Med Hypotheses. 82(3), 368-73.
Polyzos, S. A. (2011).  Prolonged anti-resorptive activity of zoledronic acid: evidence from postmenopausal osteopenic women and patients with Paget's disease of bone.. Clin Rheumatol. 30(1), 149-50.
Anastasilakis, A. D., Trovas G., Balanika A., Polyzos S. A., Makras P., & Tournis S. (2020).  Progression of Rebound-Associated Vertebral Fractures Following Denosumab Discontinuation Despite Reinstitution of Treatment: Suppressing Increased Bone Turnover May Not Be Enough.. J Clin Densitom.
Polyzos, S. A., Anastasilakis A. D., Litsas I., Efstathiadou Z., Kita M., Arsos G., et al. (2010).  Profound hypocalcemia following effective response to zoledronic acid treatment in a patient with juvenile Paget's disease.. J Bone Miner Metab. 28(6), 706-12.
Polyzos, S. A., Anastasilakis A. D., Iakovou I. P., & Partsalidou V. (2010).  Primary hyperparathyroidism and incidental multifocal metastatic papillary thyroid carcinoma in a man.. Arq Bras Endocrinol Metabol. 54(6), 578-82.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές